Contrast media injectors are devices used for insertion of contrast media prior to diagnostics imaging procedures such as CT and MRI scans for enhancement of the quality of images obtained. Contrast media injectors provide features such as pre-loaded protocols and safety features to avoid extravasations to assist physicians while contrast media insertion. Contrast media injectors minimize the chances of ill-effects such as air emboli formation that can be caused due to improper insertion of contrast media. Contrast media injectors are being implemented significantly as it reduces wastage of contrast media volume.
Global contrast media injectors market is expected to be valued at US$ 1,773.4 Mn by the end of 2025, owing to increasing application in drug discovery segment for drug-cell interaction analysis.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-823
Drivers and Trends
Increasing prevalence of chronic diseases such as cancer and cardiovascular disease, increasing incidence of trauma cases and rising ageing population across the globe are expected to fuel revenue growth of the global contrast media injectors market over the forecast period, owing to increasing demand for early diagnosis of chronic disease to minimize the economic burden incurred on a nation for treatment. Emergence of alternative techniques such as usage of biomarkers for detection of cancer, high costs of contrast media injectors are some of the factors expected to hamper growth of the global contrast media injectors market to a certain extent. Major trends in the contrast media injectors market include increased adoption of automated contrast media injectors especially in hospitals to couple the injectors with hospital information systems (HIS). HIS is a database where medical records of patients are stored. Contrast media injectors can automatically access the patient’s data once it is coupled with HIS, and can adjust the dose accordingly, minimizing the chances of human error.
Analysis by Region
North America is expected to dominate the global contrast media injectors market and is projected to register a CAGR of 6.2% in terms of value over the forecast period. The market in the U.S is expected to dominate the North America contrast media injectors market throughout the forecast period. North America contrast media injectors market accounted for 33.5% revenue share in 2014. Japan market is projected to witness a healthy CAGR of 5.8% during the forecast period. APEJ market is estimated to account for 10.7% revenue share in the global contrast media injectors market in 2015.
Analysis by Product
In terms of volume, CT injectors segment is expected to account for the maximum share in the global contrast media injectors market over the forecast period. MRI injectors segment is expected to register highest CAGR over the forecast period, in terms of volume. CT injectors segment is expected to dominate the global contrast media injectors market, in terms of revenue, owing to high installed base of CT scanners in hospitals across the globe as compared to other diagnostics imaging devices. In terms of volume and value, cardiology injectors segment is expected to register lowest CAGR over the forecast period.
Analysis by End User
On the basis of end user, contrast media injectors market is segmented into hospitals, ambulatory surgical centres and diagnostics centres. In terms of value and volume, diagnostics centres segment is expected to register lowest CAGR by over the forecast period. Hospitals segment revenue growth is majorly driven by increasing installations of imaging modalities in hospitals. Increasing adoption of contrast media injectors among physicians for early diagnosis of chronic disease, especially in the field of oncology and cardiology is fueling revenue growth of the contrast media injectors market.
Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-823
Key market players covered in this report are Mallinckrodt, Guerbet SA, Bayer AG, Bracco Imaging S.p.A., Ulrich GmbH & Co. KG., Medtron AG and Nemoto Kyorindo Co. Ltd. Major players in contrast media injectors market focus on enhancing their global and regional presence through introduction of novel products and strategic operational expansion. Medrad Inc. (Bayer AG) was the market leader in the global contrast media injectors market in 2014, owing to a broad product portfolio.